Janus kinase 2 inhibitors in myeloproliferative disorders

By Lucia Eugenio   Recchia Anna Grazia   Gentile Massimo   Bossio Sabrina   Vigna Ernesto   Mazzone Carla   Madeo Antonio   Morabito Lucio   Gigliotti Vincenzo   Stefano Laura De   Caruso Nadia   Servillo Pasquale   Franzese Stefania   Bisconte Maria Grazia   Gentile Carlo   Morabito Fortunato  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 41-59

Informa Healthcare

Access to resources Recommend Favorite

Janus kinase inhibitors for the treatment of myeloproliferative neoplasms

By Rosenthal Allison   Mesa Ruben A  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1265-1276

Informa Healthcare

Access to resources Recommend Favorite

Pyrrolo[2,3]pyrimidine inhibitors of Janus kinase 3 protein tyrosine kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1087-1092

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1767-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational ABC transporter inhibitors

By Falasca Marco   Linton Kenneth J.  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 657-666

Informa Healthcare

Access to resources Recommend Favorite